scispace - formally typeset
L

Loredana Arata

Researcher at Marathon Oil

Publications -  5
Citations -  96

Loredana Arata is an academic researcher from Marathon Oil. The author has contributed to research in topics: Cancer & Public health. The author has an hindex of 3, co-authored 5 publications receiving 69 citations.

Papers
More filters
Journal ArticleDOI

Phylogenetic analysis of the first four SARS-CoV-2 cases in Chile.

TL;DR: This work studied the complete genome of the first four cases of the new coronavirus disease in Chile, from patients who traveled to Europe and Southeast Asia, and reveals at least two different viral variants entries to Chilean territory, coming from Europe and Asia.
Journal ArticleDOI

Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile

TL;DR: This work presents the occurrence of genetic variants and lineages of SARS-CoV-2 in Chile during March to April 2020 and revealed a predominance of variant D614G like in Europe and the USA and the major presence of lineage B.
Journal ArticleDOI

Analysis of Mycobacterium tuberculosis Genotypic Lineage Distribution in Chile and Neighboring Countries.

TL;DR: Global analysis of MTB lineage distribution in Chile versus neighboring countries showed that evolutionary recent lineages (LAM, T and Haarlem) accounted together for 88.2% of isolates in Chile, a pattern which mirrored MTB dynasty distribution in neighboring countries.
Journal ArticleDOI

Caracterización genética de cepas de Listeria monocytogenes aisladas durante los años 2007-2014 en Chile

TL;DR: Se observo una gran variabilidad genetica in las cepas de L. monocytogenes analizadas, siendo predominantes las secuencias tipo ST1 y ST2, ambas pertenecientes al Linaje I.
Journal ArticleDOI

Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.

TL;DR: The results of this research suggest that the neutralizing epitopes of HPV-66 are antigenically different compared to HPV-16 and HPV-18, and show the need to perform new structural and immunological studies on HPV- 66 L1 protein to evaluate the cross-protection conferred by current HPV vaccines.